Its activation triggers the release of inflammatory cytokines, such as IL-1β and IL-18, enhances CD8+ T cell infiltration, and improves chemosensitivity, thereby exerting potent tumor-suppressive effects. The gene discussed is CD8A; the disease is neoplasm.